Healthcare Sector
Major Pharmaceutical Preparations Industry 
|
|
|
Data by Company within Major Pharmaceutical Preparations Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Abeona Therapeutics Inc. |
$ 652 |
$ 1 |
$ -23 |
- |
| Abbott Laboratories |
$ 91,143 |
$ 23,607 |
$ 1,171 |
77,000 |
| Arbutus Biopharma Corp |
$ 383 |
$ 2 |
$ -275 |
- |
| Acadia Pharmaceuticals Inc |
$ 4,595 |
$ 63 |
$ -338 |
- |
| Achillion Pharmaceuticals Inc |
$ 561 |
- |
$ -66 |
- |
| Acelrx Pharmaceuticals Inc |
$ 145 |
$ 16 |
$ -50 |
- |
| Acura Pharmaceuticals, Inc |
$ 5 |
$ 7 |
$ -2 |
- |
| Alcobra Ltd. |
- |
- |
$ 0 |
- |
| Adamis Pharmaceuticals Corp |
$ 136 |
$ 11 |
$ -18 |
- |
| Adamas Pharmaceuticals Inc |
$ 477 |
- |
$ -66 |
- |
| Aduro Biotech, Inc. |
$ 782 |
$ 17 |
$ -106 |
- |
| Advaxis, Inc. |
$ 192 |
$ 14 |
$ -92 |
- |
| Aegerion Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Agios Pharmaceuticals Inc |
$ 3,138 |
$ 53 |
$ -269 |
- |
| Aeglea Biotherapeutics, Inc. |
$ 67 |
$ 5 |
$ -25 |
- |
| Agile Therapeutics Inc |
$ 109 |
- |
$ -28 |
- |
| Aimmune Therapeutics, Inc. |
$ 1,200 |
- |
$ -106 |
- |
| Achaogen Inc |
$ 615 |
$ 34 |
$ -89 |
- |
| Akebia Therapeutics, Inc. |
$ 715 |
- |
$ -140 |
- |
| Akorn Inc |
$ 4,149 |
$ 1,020 |
$ 124 |
- |
| Albireo Pharma, Inc. |
$ 159 |
- |
$ 0 |
- |
| Aldeyra Therapeutics, Inc. |
$ 120 |
- |
$ -20 |
- |
| Alimera Sciences Inc |
$ 85 |
$ 36 |
$ -25 |
- |
| Alkermes Plc. |
$ 7,722 |
$ 804 |
$ -196 |
- |
| Alnylam Pharmaceuticals, Inc. |
$ 9,714 |
$ 59 |
$ -414 |
- |
| Alexza Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Alexion Pharmaceuticals Inc |
$ 32,064 |
$ 3,412 |
$ 527 |
2,273 |
| Amag Pharmaceuticals Inc. |
$ 648 |
$ 593 |
$ -45 |
- |
| Amylin Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Ampio Pharmaceuticals, Inc. |
$ 36 |
- |
$ -12 |
- |
| Amphastar Pharmaceuticals, Inc. |
$ 788 |
$ 252 |
$ 9 |
- |
| Amarin Corp Plcuk |
$ 877 |
$ 151 |
$ -78 |
- |
| Anacor Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Ani Pharmaceuticals Inc |
$ 594 |
$ 158 |
$ 5 |
- |
| Antriabio, Inc. |
$ 44 |
- |
$ -21 |
- |
| Anthera Pharmaceuticals Inc |
$ 14 |
- |
$ -43 |
- |
| Apricus Biosciences, Inc. |
$ 19 |
- |
$ 6 |
- |
| Aquinox Pharmaceuticals, Inc |
$ 320 |
- |
$ -41 |
- |
| Ardelyx, Inc. |
$ 256 |
- |
$ -166 |
- |
| Argos Therapeutics Inc |
$ 7 |
$ 1 |
$ -64 |
- |
| Aralez Pharmaceuticals Inc. |
$ 100 |
- |
$ 0 |
- |
| Arena Pharmaceuticals Inc |
$ 759 |
$ 118 |
$ -20 |
- |
| Arqule Inc |
$ 80 |
- |
$ -30 |
- |
| Array Biopharma Inc |
$ 1,957 |
$ 151 |
$ -117 |
- |
| Athersys, Inc |
$ 252 |
$ 3 |
$ 0 |
- |
| Actinium Pharmaceuticals, Inc. |
$ 34 |
- |
$ -28 |
- |
| Avenue Therapeutics, Inc. |
$ 19 |
- |
$ 0 |
- |
| Avadel Pharmaceuticals Plc |
$ 411 |
- |
$ 0 |
- |
| Aveo Pharmaceuticals Inc |
$ 283 |
$ 4 |
$ -28 |
- |
| Aoxing Pharmaceutical Company, Inc. |
$ 19 |
$ 30 |
$ -1 |
- |
| Axsome Therapeutics, Inc. |
$ 109 |
- |
$ 0 |
- |
| Biodelivery Sciences International Inc |
$ 155 |
$ 42 |
$ 0 |
- |
| Beigene, Ltd. |
$ 43,944 |
- |
$ 0 |
- |
| Dnib Unwind, Inc. |
- |
- |
$ 0 |
- |
| Biodel Inc |
- |
- |
$ 0 |
- |
| Bellicum Pharmaceuticals, Inc. |
$ 373 |
$ 1 |
$ -84 |
- |
| Bellerophon Therapeutics, Inc. |
$ 36 |
- |
$ -54 |
- |
| Biomarin Pharmaceutical Inc |
$ 16,290 |
$ 1,201 |
$ -175 |
- |
| Bristol Myers Squibb Co |
$ 103,365 |
$ 20,238 |
$ 4,561 |
25,000 |
| Fitlife Brands, Inc. |
- |
- |
$ 0 |
- |
| Blueprint Medicines Corp |
$ 2,422 |
$ 26 |
$ -99 |
- |
| Biostar Pharmaceuticals, Inc. |
$ 4 |
- |
$ -6 |
- |
| Biospecifics Technologies Corp |
$ 340 |
$ 27 |
$ 12 |
- |
| Baxalta Inc |
- |
- |
$ 0 |
- |
| Beyondspring Inc. |
$ 785 |
- |
$ 0 |
- |
| Calithera Biosciences, Inc. |
$ 573 |
- |
$ -29 |
- |
| Catabasis Pharmaceuticals Inc |
$ 39 |
- |
$ -32 |
- |
| Cymabay Therapeutics, Inc. |
$ 217 |
- |
$ -27 |
- |
| Cambrex Corp |
$ 1,789 |
$ 517 |
$ 91 |
- |
| Columbia Laboratories Inc |
- |
- |
$ 0 |
- |
| Carbylan Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Chemocentryx, Inc. |
$ 347 |
$ 24 |
$ -32 |
- |
| Celgene Corp |
$ 116,682 |
$ 12,191 |
$ 2,602 |
6,012 |
| Chembio Diagnostics, Inc. |
$ 75 |
$ 18 |
$ -8 |
- |
| Cempra, Inc. |
$ 163 |
$ 18 |
$ -99 |
- |
| Cerulean Pharma Inc. |
- |
- |
$ -39 |
- |
| Ceres Ventures, Inc. |
- |
- |
$ 0 |
- |
| Contrafect Corp |
$ 42 |
- |
$ -26 |
- |
| Chiasma, Inc |
$ 60 |
- |
$ -31 |
- |
| China Pharma Holdings, Inc. |
- |
- |
$ 0 |
- |
| Checkpoint Therapeutics, Inc. |
$ 192 |
- |
$ 0 |
- |
| Colucid Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Cellectar Biosciences, Inc. |
$ 24 |
- |
$ -11 |
- |
| Clearside Biomedical, Inc. |
$ 206 |
$ 0 |
$ -19 |
- |
| Celsion Corp |
$ 10 |
$ 1 |
$ -22 |
- |
| Clovis Oncology, Inc. |
$ 3,476 |
- |
$ -370 |
- |
| Chimerix Inc |
$ 236 |
$ 4 |
$ -66 |
- |
| Conatus Pharmaceuticals Inc. |
$ 155 |
- |
$ -25 |
- |
| Concert Pharmaceuticals, Inc. |
$ 326 |
$ 0 |
$ 0 |
- |
| Coronado Biosciences Inc |
- |
- |
$ 0 |
- |
| Global Green Inc. |
- |
- |
$ 0 |
- |
| Collegium Pharmaceutical, Inc |
$ 296 |
$ 7 |
$ -98 |
- |
| Corium International, Inc. |
$ 341 |
$ 30 |
$ -44 |
- |
| Corcept Therapeutics Inc |
$ 2,154 |
$ 109 |
$ 24 |
- |
| China Pharma Holdings, Inc. |
$ 9 |
$ 15 |
$ -9 |
- |
| Cumberland Pharmaceuticals Inc |
$ 114 |
$ 35 |
$ -2 |
- |
| Catalyst Pharmaceuticals, Inc. |
$ 205 |
- |
$ -17 |
- |
| Corbus Pharmaceuticals Holdings, Inc. |
$ 329 |
$ 3 |
$ -28 |
- |
| Cormedix Inc. |
- |
- |
$ 0 |
- |
| Cardiome Pharma Corp |
- |
- |
$ 0 |
- |
| Crispr Therapeutics Ag |
- |
- |
$ 0 |
- |
| Corvus Pharmaceuticals, Inc. |
$ 327 |
- |
$ 0 |
- |
| Cti Biopharma Corp. |
$ 105 |
$ 37 |
$ -50 |
- |
| Catalent, Inc. |
$ 5,703 |
$ 2,075 |
$ 110 |
- |
| Contravir Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Cyclacel Pharmaceuticals, Inc. |
$ 10 |
- |
$ -9 |
- |
| China Yct International Group, Inc. |
$ 12 |
$ 64 |
$ 12 |
- |
| Cymabay Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Cytokinetics Inc |
$ 685 |
$ 101 |
$ 0 |
- |
| Dara Biosciences, Inc. |
- |
- |
$ 0 |
- |
| Depomed Inc |
$ 370 |
$ 425 |
$ -111 |
- |
| Dermira, Inc. |
$ 1,104 |
$ 25 |
$ -101 |
- |
| Pronai Therapeutics Inc |
- |
- |
$ 0 |
- |
| Dipexium Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Dicerna Pharmaceuticals Inc |
$ 94 |
$ 1 |
$ -58 |
- |
| Durect Corp |
$ 241 |
$ 16 |
$ -36 |
- |
| Dynavax Technologies Corp |
$ 1,034 |
$ 9 |
$ -101 |
- |
| Eleven Biotherapeutics, Inc. |
$ 40 |
$ 1 |
$ 3 |
- |
| Endocyte Inc |
$ 59 |
$ 0 |
$ -43 |
- |
| Egalet Corp |
$ 36 |
$ 23 |
$ -100 |
- |
| Eagle Pharmaceuticals, Inc. |
$ 928 |
$ 237 |
$ 105 |
- |
| Elite Pharmaceuticals Inc |
$ 96 |
$ 10 |
$ 25 |
- |
| Emisphere Technologies Inc |
$ 24 |
$ 1 |
$ -2 |
- |
| Endo International Plc |
$ 1,964 |
$ 1,691 |
$ -3,288 |
- |
| Enanta Pharmaceuticals Inc |
$ 837 |
$ 40 |
$ -21 |
- |
| Epirus Biopharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Epizyme, Inc. |
$ 1,092 |
- |
$ -120 |
- |
| Esperion Therapeutics, Inc. |
$ 1,115 |
- |
$ -130 |
- |
| Evoke Pharma Inc |
$ 53 |
- |
$ -11 |
- |
| Eyegate Pharmaceuticals Inc |
$ 13 |
$ 1 |
$ -13 |
- |
| Fortress Biotech, Inc. |
$ 182 |
$ 64 |
$ -69 |
- |
| Fibrocell Science, Inc. |
$ 54 |
- |
$ -29 |
- |
| Fibrogen Inc |
$ 3,684 |
$ 118 |
$ -124 |
- |
| Flex Pharma, Inc. |
$ 62 |
$ 1 |
$ -36 |
- |
| Flamel Technologies Sa |
- |
- |
$ 0 |
- |
| Flexion Therapeutics Inc |
$ 849 |
- |
$ -94 |
- |
| Fresenius Medical Care Ag & Co. Kgaa |
- |
- |
$ 0 |
- |
| Antriabio, Inc. |
- |
- |
$ 0 |
- |
| Amicus Therapeutics Inc |
$ 2,257 |
$ 16 |
$ -208 |
- |
| Five Prime Therapeutics Inc |
$ 985 |
$ 36 |
$ -106 |
- |
| Fitlife Brands, Inc. |
$ 3 |
$ 25 |
$ 0 |
- |
| Futureworld Corp. |
- |
- |
$ 0 |
- |
| Galectin Therapeutics Inc |
$ 65 |
- |
$ -19 |
- |
| Globeimmune Inc |
- |
- |
$ 0 |
- |
| Gb Sciences Inc |
$ 29 |
- |
$ -10 |
- |
| Global Blood Therapeutics, Inc. |
$ 1,169 |
- |
$ -95 |
- |
| Gemphire Therapeutics Inc. |
$ 109 |
- |
$ 0 |
- |
| Geron Corp |
$ 347 |
$ 6 |
$ -28 |
- |
| Guardion Health Sciences, Inc. |
- |
- |
$ 0 |
- |
| Galmed Pharmaceuticals Ltd. |
$ 96 |
- |
$ 0 |
- |
| Glycomimetics Inc |
$ 383 |
- |
$ -51 |
- |
| Generex Biotechnology Corp |
$ 3 |
- |
$ -52 |
- |
| Genspera Inc |
- |
- |
$ 0 |
- |
| Genvec Inc |
$ 16 |
$ 0 |
$ -8 |
- |
| Global Green Inc. |
- |
- |
$ 0 |
- |
| Hutchison China Meditech Ltd |
$ 1,559 |
- |
$ 0 |
- |
| Heron Therapeutics, Inc. |
$ 766 |
- |
$ -190 |
- |
| HOSPIRA, INC. |
- |
- |
$ 0 |
- |
| Heat Biologics, Inc. |
$ 22 |
- |
$ -11 |
- |
| Horizon Pharma Plc |
$ 1,999 |
$ 1,029 |
$ -437 |
- |
| Imagenetix Inc |
- |
- |
$ 0 |
- |
| Ibio, Inc. |
$ 31 |
$ 0 |
$ -16 |
- |
| Intercept Pharmaceuticals Inc |
$ 1,845 |
$ 71 |
$ -385 |
- |
| Immune Design Corp. |
$ 265 |
$ 16 |
$ -53 |
- |
| Immunogen Inc |
$ 567 |
$ 89 |
$ -118 |
- |
| Imprimis Pharmaceuticals, Inc. |
$ 39 |
$ 24 |
$ -13 |
- |
| Immune Pharmaceuticals Inc |
$ 11 |
- |
$ -38 |
- |
| Immunocellular Therapeutics, Ltd. |
$ 1 |
- |
$ -21 |
- |
| Innocoll Holdings Plc |
$ 69 |
- |
$ 0 |
- |
| Insmed Inc |
$ 1,794 |
- |
$ -188 |
- |
| Insite Vision Inc |
- |
- |
$ 0 |
- |
| Insys Therapeutics, Inc. |
$ 640 |
$ 206 |
$ -6 |
- |
| Intellipharmaceutics International Inc. |
- |
- |
$ 0 |
- |
| Impax Laboratories Inc |
$ 1,709 |
$ 813 |
$ -578 |
- |
| Ironwood Pharmaceuticals Inc |
$ 2,309 |
$ 271 |
$ -143 |
- |
| Ionis Pharmaceuticals Inc |
- |
$ 486 |
$ 25 |
- |
| Intra-cellular Therapies, Inc. |
$ 836 |
$ 0 |
$ -102 |
- |
| Inotek Pharmaceuticals Corporation |
$ 41 |
- |
$ -41 |
- |
| Jaguar Health, Inc. |
$ 6 |
$ 2 |
$ -14 |
- |
| Jazz Pharmaceuticals Plc |
$ 9,083 |
$ 1,541 |
$ 404 |
- |
| Johnson & Johnson |
$ 360,233 |
$ 72,531 |
$ 16,500 |
126,500 |
| Juniper Pharmaceuticals Inc |
$ 49 |
$ 58 |
$ 8 |
- |
| Kalobios Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Kalvista Pharmaceuticals, Inc. |
$ 43 |
- |
$ 0 |
- |
| Humanigen, Inc |
$ 33 |
- |
$ -21 |
- |
| Kadmon Holdings, Inc. |
$ 184 |
- |
$ 0 |
- |
| Keryx Biopharmaceuticals Inc |
$ 779 |
$ 43 |
$ -185 |
- |
| Keyuan Petrochemicals, Inc. |
- |
- |
$ 0 |
- |
| Kindred Biosciences, Inc. |
$ 172 |
- |
$ -25 |
- |
| Kempharm, Inc |
$ 53 |
- |
$ -46 |
- |
| Karyopharm Therapeutics Inc. |
$ 480 |
$ 0 |
$ -112 |
- |
| China Shenghuo Pharmaceutical Holdings Inc |
- |
- |
$ 0 |
- |
| Kura Oncology, Inc. |
- |
- |
$ 0 |
- |
| Kythera Biopharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Lannett Co Inc |
$ 640 |
$ 633 |
$ -1 |
- |
| Lifevantage Corp |
$ 59 |
$ 199 |
$ 2 |
- |
| Ligand Pharmaceuticals Inc |
$ 3,153 |
$ 117 |
$ 9 |
- |
| Lilly Eli & Co |
$ 88,374 |
$ 22,005 |
$ 2,447 |
39,135 |
| Loxo Oncology, Inc. |
$ 2,387 |
- |
$ -100 |
- |
| Lipocine Inc. |
$ 80 |
- |
$ -17 |
- |
| Lexicon Pharmaceuticals, Inc. |
$ 1,349 |
$ 78 |
$ -144 |
- |
| Merrimack Pharmaceuticals Inc |
$ 1,946 |
- |
$ -145 |
- |
| Mabcure Inc. |
- |
- |
$ 0 |
- |
| Moleculin Biotech, Inc. |
$ 45 |
- |
$ -6 |
- |
| Seres Therapeutics, Inc. |
$ 677 |
$ 22 |
$ -97 |
- |
| Medicines Co |
$ 2,514 |
$ 106 |
$ -709 |
- |
| Medivation, Inc. |
- |
- |
$ 0 |
- |
| Mei Pharma, Inc. |
$ 201 |
$ 23 |
$ 3 |
- |
| Macrogenics Inc |
$ 604 |
$ 12 |
$ -147 |
- |
| Mmrglobal, Inc. |
- |
- |
$ 0 |
- |
| Mallinckrodt Plc |
$ 3,441 |
$ 3,183 |
$ 776 |
- |
| Mannkind Corp |
$ 194 |
$ 180 |
$ 129 |
- |
| Medicinova Inc |
$ 204 |
- |
$ -10 |
- |
| Merck & Co., Inc. |
$ 178,593 |
$ 40,015 |
$ 5,109 |
70,000 |
| Marinus Pharmaceuticals Inc |
$ 96 |
- |
$ -22 |
- |
| Mirati Therapeutics, Inc. |
$ 258 |
- |
$ -75 |
- |
| Mast Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Mylan N.v. |
$ 16,655 |
$ 11,605 |
$ 533 |
25,000 |
| Myos Rens Technology Inc. |
$ 8 |
$ 0 |
$ -4 |
- |
| Myovant Sciences Ltd. |
$ 730 |
- |
$ 0 |
- |
| Natures Sunshine Products Inc |
$ 202 |
$ 339 |
$ 8 |
- |
| Nabriva Therapeutics Plc |
$ 227 |
- |
$ 0 |
- |
| Novabay Pharmaceuticals, Inc. |
$ 69 |
$ 15 |
$ -11 |
- |
| Neos Therapeutics, Inc. |
$ 202 |
$ 16 |
$ -80 |
- |
| Neothetics, Inc. |
$ 5 |
- |
$ -10 |
- |
| Minerva Neurosciences, Inc. |
$ 252 |
- |
$ -38 |
- |
| China Nuokang Bio-pharmaceutical Inc. |
- |
- |
$ 0 |
- |
| Nektar Therapeutics |
$ 3,398 |
$ 133 |
$ -209 |
- |
| Newlink Genetics Corp |
$ 316 |
$ 41 |
$ -67 |
- |
| Novan, Inc. |
$ 88 |
- |
$ -21 |
- |
| Inergetics Inc |
- |
- |
$ 0 |
- |
| Nephrogenex, Inc. |
- |
- |
$ 0 |
- |
| Inspyr Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Neurotrope, Inc. |
$ 45 |
- |
$ -12 |
- |
| Nexvet Biopharma Plc |
$ 79 |
- |
$ -20 |
- |
| Novelion Therapeutics Inc. |
- |
- |
$ 0 |
- |
| Nivalis Therapeutics, Inc. |
$ 38 |
- |
$ -18 |
- |
| Novelos Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Northwest Biotherapeutics Inc |
$ 36 |
$ 0 |
$ -86 |
- |
| Northwest Biotherapeutics Inc |
- |
- |
$ 0 |
- |
| Ocera Therapeutics, Inc. |
$ 32 |
- |
$ -27 |
- |
| Ocular Therapeutix, Inc. |
$ 184 |
$ 2 |
$ -57 |
- |
| Oragenics Inc |
$ 18 |
- |
$ -8 |
- |
| Ohr Pharmaceutical Inc |
$ 41 |
- |
$ -25 |
- |
| Oncomed Pharmaceuticals Inc |
$ 166 |
$ 25 |
$ -86 |
- |
| Omeros Corp |
$ 924 |
$ 54 |
$ -63 |
- |
| Oncosec Medical Inc |
- |
- |
$ 0 |
- |
| Onconova Therapeutics, Inc. |
$ 16 |
$ 2 |
$ -18 |
- |
| Ophthotech Corp. |
$ 96 |
$ 10 |
$ -193 |
- |
| Opko Health, Inc. |
$ 3,656 |
$ 1,184 |
$ -77 |
- |
| Opexa Therapeutics, Inc. |
$ 7 |
- |
$ -5 |
- |
| Orexigen Therapeutics, Inc. |
$ 35 |
$ 63 |
$ -77 |
- |
| Oramed Pharmaceuticals Inc. |
$ 126 |
- |
$ 7 |
- |
| Oragenics Inc |
- |
- |
$ 0 |
- |
| Bioblast Pharma Ltd. |
- |
- |
$ 0 |
- |
| Otonomy, Inc. |
$ 104 |
$ 1 |
$ -104 |
- |
| Ovascience, Inc. |
$ 51 |
$ 0 |
$ -75 |
- |
| Phibro Animal Health Corp |
$ 1,421 |
$ 764 |
$ 65 |
- |
| Prestige Brands Holdings, Inc. |
$ 2,639 |
$ 929 |
$ 109 |
- |
| Puma Biotechnology, Inc. |
$ 3,877 |
- |
$ -289 |
- |
| Pacira Pharmaceuticals, Inc. |
$ 1,464 |
$ 281 |
$ -66 |
- |
| Aratana Therapeutics, Inc. |
$ 236 |
$ 47 |
$ -15 |
- |
| Pfizer Inc |
- |
- |
$ 0 |
78,300 |
| Pfenex Inc. |
$ 73 |
$ 60 |
$ 4 |
- |
| Progenics Pharmaceuticals Inc |
$ 489 |
$ 64 |
$ -4 |
- |
| Pharmathene, Inc |
- |
$ 5 |
$ 114 |
- |
| Peak Pharmaceuticals, Inc. |
$ 2 |
- |
$ 0 |
- |
| Pozen Inc |
- |
- |
$ 0 |
- |
| Propanc Biopharma, Inc. |
- |
- |
$ -9 |
- |
| Peregrine Pharmaceuticals Inc |
$ 140 |
$ 79 |
$ -18 |
- |
| Perrigo Co Plc |
$ 12,186 |
$ 5,025 |
$ -2,947 |
- |
| Prophase Labs, Inc. |
$ 38 |
$ 15 |
$ 42 |
- |
| Prothena Corp Plc |
$ 2,477 |
$ 28 |
$ -145 |
- |
| Paratek Pharmaceuticals, Inc. |
$ 678 |
- |
$ -96 |
- |
| Protect Pharmaceutical Corp |
$ 1 |
- |
$ 0 |
- |
| Protalex Inc |
$ 26 |
- |
$ -5 |
- |
| Proto Script Pharmaceutical Corp |
$ 58 |
- |
$ 0 |
- |
| Ptc Therapeutics, Inc. |
$ 794 |
$ 123 |
$ -108 |
- |
| Patheon N.v. |
$ 5,116 |
- |
$ 0 |
- |
| Pain Therapeutics Inc |
- |
- |
$ 0 |
- |
| Portola Pharmaceuticals Inc |
$ 2,992 |
$ 32 |
$ -245 |
- |
| Palatin Technologies Inc |
$ 118 |
- |
$ -40 |
- |
| Pernix Therapeutics Holdings, Inc. |
$ 29 |
$ 142 |
$ -109 |
- |
| Provectus Biopharmaceuticals, Inc. |
$ 9 |
- |
$ -23 |
- |
| Phaserx, Inc. |
- |
- |
$ 0 |
- |
| Novelion Therapeutics Inc. |
- |
- |
$ 0 |
- |
| Uniqure N.v. |
$ 243 |
- |
$ 0 |
- |
| Ultragenyx Pharmaceutical Inc. |
$ 2,224 |
- |
$ -277 |
- |
| Ra Pharmaceuticals, Inc. |
$ 337 |
- |
$ 0 |
- |
| Rock Creek Pharmaceuticals, Inc. |
- |
- |
$ 0 |
5 |
| Radius Health, Inc. |
$ 1,513 |
- |
$ -211 |
- |
| Regeneron Pharmaceuticals Inc |
$ 50,340 |
$ 5,236 |
$ 1,170 |
- |
| Reliv International Inc |
$ 13 |
$ 44 |
$ 0 |
- |
| Recro Pharma, Inc. |
$ 161 |
$ 70 |
$ -33 |
- |
| Reata Pharmaceuticals Inc |
$ 707 |
$ 51 |
$ -18 |
- |
| Regulus Therapeutics Inc. |
$ 70 |
$ 0 |
$ -81 |
- |
| Rigel Pharmaceuticals Inc |
$ 292 |
$ 19 |
$ -73 |
- |
| Relypsa Inc |
- |
- |
$ 0 |
- |
| Rexahn Pharmaceuticals, Inc. |
$ 68 |
- |
$ -24 |
- |
| Rosetta Genomics Ltd. |
- |
- |
$ 0 |
- |
| Raptor Pharmaceutical Corp |
- |
- |
$ 0 |
- |
| Retrophin, Inc. |
$ 889 |
$ 138 |
$ -70 |
- |
| Ritter Pharmaceuticals Inc |
$ 7 |
- |
$ -15 |
- |
| Revance Therapeutics, Inc. |
$ 725 |
$ 0 |
$ -99 |
- |
| Ignyta, Inc. |
$ 621 |
- |
$ -118 |
- |
| Rxi Pharmaceuticals Corp |
$ 11 |
- |
$ -13 |
- |
| Sage Therapeutics, Inc. |
$ 2,428 |
- |
$ -221 |
- |
| Spring Bank Pharmaceuticals, Inc. |
$ 148 |
- |
$ -22 |
- |
| Sciclone Pharmaceuticals Inc |
$ 594 |
$ 172 |
$ 43 |
- |
| Sucampo Pharmaceuticals, Inc. |
$ 547 |
$ 247 |
$ -153 |
- |
| Scynexis Inc |
$ 61 |
$ 0 |
$ -24 |
- |
| Sagent Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Signpath Pharma, Inc. |
- |
- |
$ 0 |
- |
| Synergy Pharmaceuticals, Inc. |
$ 569 |
- |
$ -203 |
- |
| Shire Plc |
- |
$ 14,576 |
$ 652 |
- |
| Shire Plc |
- |
- |
$ 0 |
- |
| Siga Technologies Inc |
- |
- |
$ 0 |
- |
| Siga Technologies Inc |
- |
$ 6 |
$ -32 |
- |
| Sunset Island Group, Inc |
- |
- |
$ 0 |
- |
| Skystar Bio-pharmaceutical Co |
- |
- |
$ 0 |
- |
| Sibannac, Inc. |
$ 1 |
$ 0 |
$ 0 |
- |
| Sunesis Pharmaceuticals Inc |
$ 44 |
$ 3 |
$ -36 |
- |
| Madrigal Pharmaceuticals, Inc. |
- |
- |
$ -31 |
- |
| Sophiris Bio Inc. |
$ 68 |
$ 0 |
$ -7 |
- |
| Spectrum Pharmaceuticals Inc |
$ 771 |
$ 131 |
$ -85 |
- |
| Sarepta Therapeutics, Inc. |
$ 2,589 |
- |
$ -124 |
- |
| Sierra Oncology, Inc. |
$ 83 |
- |
$ 0 |
- |
| Steadymed Ltd. |
$ 82 |
$ 1 |
$ 39 |
- |
| Stemline Therapeutics Inc |
$ 258 |
$ 1 |
$ -50 |
- |
| Supernus Pharmaceuticals Inc |
$ 2,097 |
$ 253 |
$ 104 |
- |
| Sinovac Biotech Ltd |
- |
- |
$ 0 |
- |
| Savara Inc. |
$ 131 |
- |
$ 0 |
- |
| Growblox Sciences, Inc. |
- |
- |
$ 0 |
- |
| Synthetic Biologics, Inc. |
$ 118 |
- |
$ -18 |
- |
| Syros Pharmaceuticals, Inc. |
$ 396 |
- |
$ 0 |
- |
| Taro Pharmaceutical Industries Ltd |
- |
- |
$ 0 |
- |
| Theravance Biopharma, Inc. |
$ 1,729 |
$ 33 |
$ -214 |
- |
| Teva Pharmaceutical Industries Ltd |
$ 17,442 |
$ 22,723 |
$ 319 |
- |
| Threshold Pharmaceuticals Inc |
$ 39 |
- |
$ -13 |
- |
| Innoviva, Inc. |
- |
$ 176 |
$ 92 |
- |
| Tokai Pharmaceuticals Inc |
- |
- |
$ -30 |
- |
| Tetralogic Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
| Tonix Pharmaceuticals Holding Corp. |
$ 31 |
- |
$ -25 |
- |
| Tianyin Pharmaceutical Co., Inc. |
- |
- |
$ 0 |
- |
| Tapimmune Inc. |
$ 26 |
- |
$ 0 |
- |
| Trevena Inc |
$ 146 |
- |
$ -107 |
- |
| Transcept Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Tesaro, Inc. |
$ 6,406 |
$ 40 |
$ -527 |
- |
| Titan Pharmaceuticals Inc |
$ 34 |
$ 0 |
$ -11 |
- |
| Tetraphase Pharmaceuticals Inc |
$ 262 |
$ 5 |
$ -105 |
- |
| Therapeuticsmd, Inc. |
$ 1,267 |
$ 18 |
$ -89 |
- |
| Shineco, Inc. |
$ 71 |
- |
$ 0 |
- |
| United Therapeutics Corp |
$ 5,184 |
$ 1,632 |
$ 395 |
- |
| Vaccinogen Inc |
- |
- |
$ 0 |
- |
| Viking Therapeutics, Inc. |
$ 28 |
- |
$ -16 |
- |
| Vanda Pharmaceuticals Inc. |
$ 843 |
$ 156 |
$ -10 |
- |
| Vertex Pharmaceuticals Inc |
$ 38,264 |
$ 2,131 |
$ 269 |
- |
| Valeant Pharmaceuticals International, Inc. |
$ 4,982 |
$ 14,016 |
$ -1,139 |
- |
| Versartis, Inc. |
$ 763 |
- |
$ -118 |
- |
| Verastem, Inc. |
$ 179 |
- |
$ -46 |
- |
| Vitae Pharmaceuticals, Inc |
- |
- |
$ 0 |
- |
| Vital Therapies Inc |
$ 200 |
- |
$ -47 |
- |
| Vtv Therapeutics Inc. |
$ 56 |
$ 0 |
$ -55 |
- |
| Vivus Inc |
$ 102 |
$ 133 |
$ 33 |
- |
| World Health Energy Holdings, Inc. |
$ 45 |
- |
$ 0 |
- |
| Wuxi Pharmatech (cayman) Inc. |
- |
- |
$ 0 |
- |
| Xbiotech Inc. |
$ 155 |
- |
$ -47 |
- |
| Xenon Pharmaceuticals Inc. |
$ 52 |
$ 1 |
$ -29 |
- |
| Xencor Inc |
$ 1,035 |
$ 32 |
$ -39 |
- |
| Xenoport Inc |
- |
- |
$ 0 |
- |
| Xoma Corp |
$ 159 |
$ 12 |
$ -46 |
- |
| Zafgen, Inc. |
$ 91 |
- |
$ -53 |
- |
| Zogenix, Inc. |
$ 324 |
$ 27 |
$ -85 |
- |
| Zosano Pharma Corp |
$ 38 |
- |
$ -29 |
- |
| Zs Pharma, Inc. |
- |
- |
$ 0 |
- |
| Zoetis Inc. |
$ 31,735 |
$ 5,018 |
$ 877 |
- |
| Zynerba Pharmaceuticals, Inc. |
$ 83 |
- |
$ -11 |
- |
| Ovid Therapeutics Inc. |
$ 157 |
- |
$ 0 |
- |
| Shuttle Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Major Pharmaceutical Preparations Industry |
$ 1,402,762 |
$ 302,096 |
$ 15,393 |
449,225 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Major Pharmaceutical Preparations Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Major Pharmaceutical Preparations Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter 22.22 % of companies, who provided earning outlook within Major Pharmaceutical Preparations Industry, have reiterated their earnings per share outlook for the current fiscal year unchanged. |
Earnings Estimates
decrease
Pessimism dominates within Major Pharmaceutical Preparations Industry, as most of the businesses cut their earnings guidance, staggering 44.44 % have revised down earnings outlook. Overall earnings expectations for the Major Pharmaceutical Preparations Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 33.33 % of companies, who have issued revenue expectation within Major Pharmaceutical Preparations Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
As even more corporations reiterate their sales projections, 66.67 % of businesses within Major Pharmaceutical Preparations Industry, while corporate executives do not expect any change of economic environment. |
Sales Outlook decrease
In Major Pharmaceutical Preparations Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
| Cardiovascular Segment |
| Revenues |
Income |
|
24.1% |
-16.78% |
377.7% |
-84.61% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Neuroscience Segment |
| Revenues |
Income |
|
- |
- |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Anti-Infective Segment |
| Revenues |
Income |
|
14.75% |
-7.45% |
23.14% |
-12.12% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Respiratory Segment |
| Revenues |
Income |
|
24.1% |
-16.78% |
377.7% |
-84.61% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Arthritis & Pain Segment |
| Revenues |
Income |
|
24.3% |
7.73% |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Urology Segment |
| Revenues |
Income |
|
24.1% |
-16.78% |
377.7% |
-84.61% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Oncology Segment |
| Revenues |
Income |
|
9.97% |
1.68% |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Endocrine Segment |
| Revenues |
Income |
|
-34.8% |
-30.47% |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
|
|
